Ems M, Brichkina A, Lauth M
Oncogene. 2025; 44(6):341-347.
PMID: 39863750
PMC: 11790486.
DOI: 10.1038/s41388-025-03275-6.
Filipovich E, Gorodkova E, Shcherbakova A, Asaad W, Popov S, Melnichenko G
Heliyon. 2025; 11(1):e41457.
PMID: 39834406
PMC: 11742855.
DOI: 10.1016/j.heliyon.2024.e41457.
Spiridon-Bodi M, Ros-Carrero C, Igual J, Gomar-Alba M
Cell Commun Signal. 2025; 23(1):31.
PMID: 39819572
PMC: 11737188.
DOI: 10.1186/s12964-025-02027-z.
Pellarin I, DallAcqua A, Favero A, Segatto I, Rossi V, Crestan N
Signal Transduct Target Ther. 2025; 10(1):11.
PMID: 39800748
PMC: 11734941.
DOI: 10.1038/s41392-024-02080-z.
Hwang Y, Kim M
Int J Mol Sci. 2025; 26(1.
PMID: 39796178
PMC: 11719884.
DOI: 10.3390/ijms26010322.
Cell cycle progression of under-replicated cells.
Huang M, Yang C, Nie L, Zhang H, Zhu D, Wang C
Nucleic Acids Res. 2025; 53(1).
PMID: 39778868
PMC: 11707533.
DOI: 10.1093/nar/gkae1311.
Potential mutagenicity of aflatoxin B1 in Egyptian spices.
Geoshi B, El-Akabawy G, Metwally M, Soliman M
BMC Genomics. 2025; 26(1):9.
PMID: 39762744
PMC: 11705875.
DOI: 10.1186/s12864-024-11154-9.
Mms22-Rtt107 axis attenuates the DNA damage checkpoint and the stability of the Rad9 checkpoint mediator.
Wan B, Guan D, Li S, Chwat-Edelstein T, Zhao X
Nat Commun. 2025; 16(1):311.
PMID: 39746913
PMC: 11697250.
DOI: 10.1038/s41467-024-54624-0.
Overexpression of GFP Fusions of Regulators of the SAC from Arabidopsis thaliana.
Pain C
Methods Mol Biol. 2024; 2874:21-32.
PMID: 39614044
DOI: 10.1007/978-1-0716-4236-8_3.
DNA damage and repair in patients undergoing myocardial perfusion single-photon emission computed tomography.
De Lorenzo A, Dos Santos Fernandes M, Romeiro F, Arpini A, Monteiro Dias G
Sci Rep. 2024; 14(1):13079.
PMID: 38844507
PMC: 11156974.
DOI: 10.1038/s41598-024-63537-3.
The Mms22-Rtt107 axis dampens the DNA damage checkpoint by reducing the stability of the Rad9 checkpoint mediator.
Zhao X, Wan B, Guan D, Li S, Chwat-Edelstein T
Res Sq. 2024; .
PMID: 38826278
PMC: 11142307.
DOI: 10.21203/rs.3.rs-4417144/v1.
Clinicopathological Significance of Cyclin-Dependent Kinase 2 (CDK2) in Ductal Carcinoma In Situ and Early-Stage Invasive Breast Cancers.
Lashen A, Alqahtani S, Shoqafi A, Algethami M, Jeyapalan J, Mongan N
Int J Mol Sci. 2024; 25(9).
PMID: 38732271
PMC: 11084890.
DOI: 10.3390/ijms25095053.
Chromothripsis: an emerging crossroad from aberrant mitosis to therapeutic opportunities.
Ejaz U, Dou Z, Yao P, Wang Z, Liu X, Yao X
J Mol Cell Biol. 2024; 16(4).
PMID: 38710586
PMC: 11487160.
DOI: 10.1093/jmcb/mjae016.
The Clinicopathological Significance of the Cyclin D1/E1-Cyclin-Dependent Kinase (CDK2/4/6)-Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers.
Lashen A, Algethami M, Alqahtani S, Shoqafi A, Sheha A, Jeyapalan J
Int J Mol Sci. 2024; 25(7).
PMID: 38612869
PMC: 11012085.
DOI: 10.3390/ijms25074060.
Srs2 binding to PCNA and its sumoylation contribute to RPA antagonism during the DNA damage response.
Fan J, Dhingra N, Yang T, Yang V, Zhao X
bioRxiv. 2024; .
PMID: 38586001
PMC: 10996639.
DOI: 10.1101/2024.03.28.587206.
Cellular plasticity and fate determination in gastric carcinogenesis.
He Z, Hu X, He T, Zhao T
iScience. 2024; 27(4):109465.
PMID: 38550991
PMC: 10973593.
DOI: 10.1016/j.isci.2024.109465.
Editorial: Molecular architecture and dynamics of meiotic chromosomes.
Benavente R, Pradillo M, San-Segundo P
Front Cell Dev Biol. 2024; 12:1386038.
PMID: 38500684
PMC: 10944903.
DOI: 10.3389/fcell.2024.1386038.
Nitidine chloride inhibits G2/M phase by regulating the p53/14-3-3 Sigma/CDK1 axis for hepatocellular carcinoma treatment.
Zhang B, Zhou B, Huang G, Huang J, Lin X, Li Z
Heliyon. 2024; 10(1):e24012.
PMID: 38283241
PMC: 10818205.
DOI: 10.1016/j.heliyon.2024.e24012.
Deciphering the prognostic significance of anoikis-related lncRNAs in invasive breast cancer: from comprehensive bioinformatics analysis to functional experimental validation.
Dong W, Li J, Zhuang Z
Aging (Albany NY). 2024; 16(1):402-430.
PMID: 38189818
PMC: 10817393.
DOI: 10.18632/aging..
Structure of the WYL-domain containing transcription activator, DriD, in complex with ssDNA effector and DNA target site.
Schumacher M, Cannistraci E, Salinas R, Lloyd D, Messner E, Gozzi K
Nucleic Acids Res. 2023; 52(3):1435-1449.
PMID: 38142455
PMC: 10853764.
DOI: 10.1093/nar/gkad1198.